
    
      This will be a single center, eight week, randomized, controlled, examiner blind, four
      treatment arms, parallel design study in participants with at least two sensitive teeth that
      meet all the criteria at the Screening and Baseline visit. Participants will be assessed at
      baseline, four and eight weeks to monitor clinical efficacy and safety.
    
  